Open collaboration is key to new drugs
Gespeichert in:
Veröffentlicht in: | Nature (London) 2012-11, Vol.491 (7422), p.40-40 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 40 |
---|---|
container_issue | 7422 |
container_start_page | 40 |
container_title | Nature (London) |
container_volume | 491 |
creator | Gruetter, Markus |
description | |
doi_str_mv | 10.1038/491040d |
format | Article |
fullrecord | <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A308005054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A308005054</galeid><sourcerecordid>A308005054</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-35e2258491029c2988b8c44b6362746595bb1e2acd8a71c445ce7ed13e47a04c3</originalsourceid><addsrcrecordid>eNp10VtLwzAUB_AgCs4pfoWi4AXpzK1t-jiGNxgOdOJjSNPT0tk1M-nQfXsztgeLkzwcyPmdw4E_QqcEDwhm4panBHOc76Ee4Ukc8lgk-6iHMRUhFiw-REfOzTDGEUl4D11MFtAE2tS1yoxVbWWaoHLBB6yC1gQNfAW5XZbuGB0UqnZwsq199HZ_Nx09huPJw9NoOA41p6wNWQSURmJ9Ak01TYXIhOY8i1lMEx5HaZRlBKjSuVAJ8Z1IQwI5YcAThblmfXS-2VuqGmTVFKa1Ss8rp-WQYeGvxhH3KtyhSmjAqto0UFT-u-PPdni9qD7lbzTYgfzLYV7pnVuvOwPetPDdlmrpnHx6fenam__tcPo-eu7qy43W1jhnoZALW82VXUmC5TpkuQ3Zy6uNdF40JVg5M0vb-Ij-0B9Hl55Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Open collaboration is key to new drugs</title><source>Nature</source><source>Alma/SFX Local Collection</source><creator>Gruetter, Markus</creator><creatorcontrib>Gruetter, Markus</creatorcontrib><identifier>ISSN: 0028-0836</identifier><identifier>EISSN: 1476-4687</identifier><identifier>DOI: 10.1038/491040d</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/337 ; 692/308 ; 692/308/2056 ; 706/648/479 ; 706/703 ; Authorship ; correspondence ; Genetic research ; Humanities and Social Sciences ; multidisciplinary ; Pharmaceutical research ; Science ; Science (multidisciplinary)</subject><ispartof>Nature (London), 2012-11, Vol.491 (7422), p.40-40</ispartof><rights>Springer Nature Limited 2012</rights><rights>COPYRIGHT 2012 Nature Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-35e2258491029c2988b8c44b6362746595bb1e2acd8a71c445ce7ed13e47a04c3</citedby><cites>FETCH-LOGICAL-c423t-35e2258491029c2988b8c44b6362746595bb1e2acd8a71c445ce7ed13e47a04c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Gruetter, Markus</creatorcontrib><title>Open collaboration is key to new drugs</title><title>Nature (London)</title><addtitle>Nature</addtitle><subject>631/337</subject><subject>692/308</subject><subject>692/308/2056</subject><subject>706/648/479</subject><subject>706/703</subject><subject>Authorship</subject><subject>correspondence</subject><subject>Genetic research</subject><subject>Humanities and Social Sciences</subject><subject>multidisciplinary</subject><subject>Pharmaceutical research</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><issn>0028-0836</issn><issn>1476-4687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp10VtLwzAUB_AgCs4pfoWi4AXpzK1t-jiGNxgOdOJjSNPT0tk1M-nQfXsztgeLkzwcyPmdw4E_QqcEDwhm4panBHOc76Ee4Ukc8lgk-6iHMRUhFiw-REfOzTDGEUl4D11MFtAE2tS1yoxVbWWaoHLBB6yC1gQNfAW5XZbuGB0UqnZwsq199HZ_Nx09huPJw9NoOA41p6wNWQSURmJ9Ak01TYXIhOY8i1lMEx5HaZRlBKjSuVAJ8Z1IQwI5YcAThblmfXS-2VuqGmTVFKa1Ss8rp-WQYeGvxhH3KtyhSmjAqto0UFT-u-PPdni9qD7lbzTYgfzLYV7pnVuvOwPetPDdlmrpnHx6fenam__tcPo-eu7qy43W1jhnoZALW82VXUmC5TpkuQ3Zy6uNdF40JVg5M0vb-Ij-0B9Hl55Q</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>Gruetter, Markus</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>AAYXX</scope><scope>CITATION</scope><scope>ATWCN</scope></search><sort><creationdate>20121101</creationdate><title>Open collaboration is key to new drugs</title><author>Gruetter, Markus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-35e2258491029c2988b8c44b6362746595bb1e2acd8a71c445ce7ed13e47a04c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>631/337</topic><topic>692/308</topic><topic>692/308/2056</topic><topic>706/648/479</topic><topic>706/703</topic><topic>Authorship</topic><topic>correspondence</topic><topic>Genetic research</topic><topic>Humanities and Social Sciences</topic><topic>multidisciplinary</topic><topic>Pharmaceutical research</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gruetter, Markus</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Middle School</collection><jtitle>Nature (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gruetter, Markus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Open collaboration is key to new drugs</atitle><jtitle>Nature (London)</jtitle><stitle>Nature</stitle><date>2012-11-01</date><risdate>2012</risdate><volume>491</volume><issue>7422</issue><spage>40</spage><epage>40</epage><pages>40-40</pages><issn>0028-0836</issn><eissn>1476-4687</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><doi>10.1038/491040d</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-0836 |
ispartof | Nature (London), 2012-11, Vol.491 (7422), p.40-40 |
issn | 0028-0836 1476-4687 |
language | eng |
recordid | cdi_gale_infotracmisc_A308005054 |
source | Nature; Alma/SFX Local Collection |
subjects | 631/337 692/308 692/308/2056 706/648/479 706/703 Authorship correspondence Genetic research Humanities and Social Sciences multidisciplinary Pharmaceutical research Science Science (multidisciplinary) |
title | Open collaboration is key to new drugs |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T14%3A08%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Open%20collaboration%20is%20key%20to%20new%20drugs&rft.jtitle=Nature%20(London)&rft.au=Gruetter,%20Markus&rft.date=2012-11-01&rft.volume=491&rft.issue=7422&rft.spage=40&rft.epage=40&rft.pages=40-40&rft.issn=0028-0836&rft.eissn=1476-4687&rft_id=info:doi/10.1038/491040d&rft_dat=%3Cgale_cross%3EA308005054%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A308005054&rfr_iscdi=true |